1. Home
  2. CMMB vs TAOP Comparison

CMMB vs TAOP Comparison

Compare CMMB & TAOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

HOLD

Current Price

$1.49

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

TAOP

Taoping Inc.

HOLD

Current Price

$1.25

Market Cap

13.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMMB
TAOP
Founded
2004
1993
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
11.2M
13.2M
IPO Year
2023
2012

Fundamental Metrics

Financial Performance
Metric
CMMB
TAOP
Price
$1.49
$1.25
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
35.5K
6.3K
Earning Date
05-21-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
101.67
N/A
EPS
0.04
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$0.14
52 Week High
$3.86
$8.78

Technical Indicators

Market Signals
Indicator
CMMB
TAOP
Relative Strength Index (RSI) 37.56 45.51
Support Level $1.41 $1.20
Resistance Level $1.64 $1.59
Average True Range (ATR) 0.10 0.07
MACD -0.02 0.00
Stochastic Oscillator 12.50 38.92

Price Performance

Historical Comparison
CMMB
TAOP

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

Share on Social Networks: